Abstract
The Tuberculosis Control Division of the Centers for Disease Control is involved with two studies of short-course chemotherapy for pulmonary tuberculosis. One is being carried out in the United States and the other in Poland. All short-course regimens being studied are of six months’ duration, and all include rifampin (R) and isoniazid (I) administered daily or intermittently for the entire duration of treatment. Some regimens also included supplemental drugs. This report presents the results of these short-course regimens 18 months after completion of therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
